Thermo Fisher Scientific Inc. (TMO)
NYSE: TMO · Real-Time Price · USD
559.65
-2.06 (-0.37%)
Jan 17, 2025, 4:00 PM EST - Market closed
Thermo Fisher Revenue
Thermo Fisher had revenue of $10.60B in the quarter ending September 28, 2024, with 0.23% growth. This brings the company's revenue in the last twelve months to $42.37B, down -2.42% year-over-year. In the year 2023, Thermo Fisher had annual revenue of $42.86B, down -4.58%.
Revenue (ttm)
$42.37B
Revenue Growth
-2.42%
P/S Ratio
5.06
Revenue / Employee
$347,295
Employees
122,000
Market Cap
214.07B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 42.86B | -2.06B | -4.58% |
Dec 31, 2022 | 44.92B | 5.70B | 14.55% |
Dec 31, 2021 | 39.21B | 6.99B | 21.71% |
Dec 31, 2020 | 32.22B | 6.68B | 26.14% |
Dec 31, 2019 | 25.54B | 1.18B | 4.86% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 400.28B |
Johnson & Johnson | 87.70B |
Merck & Co. | 63.17B |
AbbVie | 55.53B |
AstraZeneca | 51.21B |
Novartis AG | 49.94B |
Abbott Laboratories | 41.22B |
Eli Lilly and Company | 40.86B |
TMO News
- 5 days ago - Lyndra Therapeutics Announces Strategic Clinical Research and Commercial Manufacturing Services Collaboration with Thermo Fisher Scientific for Long-Acting Oral Therapies - Business Wire
- 6 days ago - Thermo Fisher Scientific Inc. (TMO) 43rd Annual J.P. Morgan Healthcare Conference (Transcript) - Seeking Alpha
- 10 days ago - Thermo Fisher Scientific's Olink Platform Selected for World's Largest Human Proteome Study - Business Wire
- 17 days ago - Thermo Fisher Scientific to Present at 43rd Annual J.P. Morgan Healthcare Conference on January 14, 2025 - Business Wire
- 18 days ago - Thermo Fisher Scientific to Hold Earnings Conference Call on Thursday, January 30, 2025 - Business Wire
- 4 weeks ago - Knipper Health Announces Transfer of Commercial Sample Management Business from Thermo Fisher Scientific - Business Wire
- 5 weeks ago - Thermo Fisher: The Cycle Has Already Turned Around - Seeking Alpha
- 5 weeks ago - Thermo Fisher Scientific: Renewed Growth Momentum After The Pandemic - Seeking Alpha